We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Drug makers target ubiquitin proteasome pathway anew.
- Authors
Sheridan, Cormac
- Abstract
The article focuses on the concerns of drug makers in targeting ubiquitin-proteasome pathway systems. Topics discussed include alliance between pharmaceuticals Nurix and Celgene to develop, and commercialize new small molecule therapeutics in oncology and inflammation, views of Gerald Gavory, head of biology at Almac Discovery, on the issue and a chart depicting selected development programs targeting the ubiquitin-proteasome system by drug developers including Amgen, and Takeda.
- Subjects
DRUG factories; UBIQUITIN; PROTEASOMES; NURIX Inc.; CELGENE Corp.; GAVORY, Gerald
- Publication
Nature Biotechnology, 2015, Vol 33, Issue 11, p1115
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt1115-1115